within Pharmacolibrary.Drugs.ATC.V;

model V09IX12
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.004666666666666667,
    adminDuration  = 600,
    adminMass      = 0.37,
    adminCount     = 1,
    Vd             = 0.00041,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Fluciclovine (18F), also known as 18F-fluciclovine or Axumin, is a radiolabeled synthetic amino acid and PET imaging agent used primarily for positron emission tomography (PET) imaging in the detection of recurrent prostate cancer. It is an approved radiotracer for this indication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult human males with suspected recurrent prostate cancer undergoing PET imaging studies with fluciclovine (18F).</p><h4>References</h4><ol><li>Funmilayo I Tade, Michael A Cohen, Toncred M Styblo, Oluwaseun A Odewole, Anna I Holbrook, Mary S Newell, Bital Savir-Baruch, Xiaoxian Li, Mark M Goodman, Jonathon A Nye, David M Schuster,Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study.,Journal of nuclear medicine : official publication, Society of Nuclear Medicine,2016<a href='https://pubmed.ncbi.nlm.nih.gov/27056619/'>https://pubmed.ncbi.nlm.nih.gov/27056619/</a></li><li>Laure Michaud, B J Beattie, T Akhurst, M Dunphy, P Zanzonico, R Finn, A Mauguen, H Sch√∂der, W A Weber, A B Lassman, R Blasberg,,European journal of nuclear medicine and molecular imaging,2020<a href='https://pubmed.ncbi.nlm.nih.gov/31418054/'>https://pubmed.ncbi.nlm.nih.gov/31418054/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V09IX12;
